Efemoral Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Efemoral Medical, Inc. - overview
Established
2015
Location
Los Altos, CA, US
Primary Industry
Healthcare
About
Based in California, US, and founded in 2015 by Christopher Haig (CEO), and Lewis Schwartzhristopher Haig, Efemoral Medical, Inc. operates as a healthcare company that develops medical devices with non-invasive therapies for those patients with peripheral vascular disease. In September 2022, Efemoral Medical, Inc. received an amount of grant funding from The National Institutes of Health.
Efemoral Medical, Inc. is a medical technology company that seeks to develop long-lasting, minimally invasive treatment medications for patients with peripheral vascular disease. The company offers a technology of multi-element bioresorbable intravascular stent that is designed to maintain or improve the functional capacity of a blood vessel and can be used in external vessels, allowing healthcare providers to treat peripheral vascular disease effectively. The company plans to use September 2022 funding to support its research and development.
Current Investors
The National Institutes of Health
Primary Industry
Healthcare
Sub Industries
Medical Equipment Distributors
Website
www.efemoralmedical.com
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.